Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
Blue Owl Capital Holdings LP | 2,010,972 3.450% |
-1,408,870 (-41.20%) |
Filing History |
| 2024-11-14 4:24 pm Purchase |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 5,796,433 9.990% |
1,403,112 (+31.94%) |
Filing History |
| 2024-11-12 2:23 pm Unchanged |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,998,714 5.170% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
BLACKROCK INC BLK |
4,338,725 7.500% |
0 (Unchanged) |
Filing History |
| 2024-11-04 11:18 am Purchase |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,998,714 5.170% |
1,227,271 (+69.28%) |
Filing History |
| 2024-10-31 12:48 pm Sale |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
FRANKLIN RESOURCES INC BEN |
2,191,262 3.800% |
-1,090,018 (-33.22%) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
BLACKROCK INC BLK |
4,338,725 7.500% |
1,589,995 (+57.84%) |
Filing History |
| 2024-06-07 1:30 pm Purchase |
2024-05-31 | 13G | Cullinan Oncology, Inc. CGEM |
BLACKROCK INC BLK |
2,748,730 4.800% |
286,456 (+11.63%) |
Filing History |
| 2024-04-24 5:50 pm Purchase |
2024-04-18 | 13G | Cullinan Oncology, Inc. CGEM |
Flynn James E | 3,283,824 5.710% |
3,283,824 (New Position) |
Filing History |
| 2024-02-14 9:01 pm Purchase |
2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
Blue Owl Capital Holdings LP | 3,419,842 7.990% |
3,419,842 (New Position) |
Filing History |
| 2024-02-14 4:59 pm Sale |
2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
Jovan-Embiricos Morana | 2,177,461 5.090% |
-1,606,510 (-42.46%) |
Filing History |
| 2024-02-14 10:16 am Sale |
2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 4,393,321 9.990% |
-3,115,738 (-41.49%) |
Filing History |
| 2024-02-13 5:02 pm Sale |
2023-12-29 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 1,771,443 4.140% |
-1,041,522 (-37.03%) |
Filing History |
| 2024-02-06 10:09 am Purchase |
2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
FRANKLIN RESOURCES INC BEN |
3,281,280 7.700% |
3,281,280 (New Position) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
BLACKROCK INC BLK |
2,462,274 5.800% |
425,623 (+20.90%) |
Filing History |
| 2023-09-07 09:38 am Sale |
2023-08-31 | 13G | Cullinan Oncology, Inc. CGEM |
BLACKROCK INC BLK |
2,036,651 4.800% |
-469,564 (-18.74%) |
Filing History |
| 2023-02-15 11:42 am Sale |
2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
Jovan-Embiricos Morana | 3,783,971 8.300% |
-2,495,742 (-39.74%) |
Filing History |
| 2023-02-14 11:53 am Purchase |
2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 7,509,059 16.400% |
2,139,600 (+39.85%) |
Filing History |
| 2023-02-13 12:36 pm Purchase |
2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
CHI Advisors LLC | 3,317,544 7.250% |
840,824 (+33.95%) |
Filing History |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,812,965 6.150% |
446,157 (+18.85%) |
Filing History |